Credit Suisse’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$460K Buy
111,078
+2,728
+3% +$11.3K ﹤0.01% 2664
2023
Q4
$283K Sell
108,350
-3,272
-3% -$8.54K ﹤0.01% 2918
2023
Q3
$209K Sell
111,622
-7,456
-6% -$13.9K ﹤0.01% 3013
2023
Q2
$299K Buy
+119,078
New +$299K ﹤0.01% 2990
2022
Q3
Sell
-14
Closed 4244
2022
Q2
$0 Buy
+14
New ﹤0.01% 4260